PodParley PodParley
Answers from the Lab cover art

All Episodes

Answers from the Lab — 379 episodes

#
Title
1

Digital Advances: What’s Next for Clinical Diagnostics?

2

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

3

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

4

How Strategic Collaborations Transform Clinical Diagnostics

5

Innovation and Resilience in Lab Logistics

6

2026 Forecast: Trends Shaping the Future of Diagnostics

7

Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely

8

Breakthroughs and Trends That Defined Lab Medicine in 2025

9

Accelerating Research and Development With BioPharma Diagnostics

10

Unlocking the Unknown With Metagenomics

11

Forging Collaborations That Deliver Better Outcomes

12

Advancing Precision Medicine Through Therapeutic Tests

13

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

14

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

15

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

16

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

17

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

18

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

19

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

20

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

21

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

22

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

23

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

24

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

25

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

26

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

27

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

28

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

29

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

30

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

31

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

32

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

33

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

34

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

35

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

36

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

37

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

38

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

39

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

40

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

41

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

42

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

43

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

44

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

45

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

46

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

47

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC

48

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

49

What’s Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D.

50

Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D.

51

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC

52

Navigating Technology Disruptions: John Osborn

53

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

54

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

55

Overcoming Health Threats Through Public-Private Lab Partnerships: Bill Morice, M.D., Ph.D.

56

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

57

Advancing Lupus Treatment With Modern Diagnostics: Bill Morice, M.D., Ph.D.

58

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

59

Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D.

60

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

61

Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.

62

Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D.

63

Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D.

64

Tracking the Latest Pathogens: Bill Morice, M.D., Ph.D.

65

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

66

Global Industry Activities: Bill Morice, M.D., Ph.D.

67

Alarming Increase in Dengue Cases: Elitza Theel, Ph.D.

68

Scaling Knowledge With AI: Bill Morice, M.D., Ph.D.

69

An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D.

70

The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D.

71

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

72

The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D.

73

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

74

Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.

75

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

76

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.

77

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.

78

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.

79

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.

80

Get to Know the DLMP Chair: Eric Hsi, M.D.

81

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

82

FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

83

The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.

84

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

85

Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

86

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D

87

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

88

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

89

Tick Season Outlook: Elitza Theel, Ph.D.

90

Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.

91

Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.

92

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

93

Why Measles Is on the Rise: Matthew Binnicker, Ph.D.

94

Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

95

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

96

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

97

Syphilis Testing Updates: Elitza Theel, Ph.D.

98

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.

99

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.

100

Black History Month: Bill Morice, M.D., Ph.D.

101

Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.

102

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.

103

Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.

104

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.

105

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

106

The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

107

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

108

Evolution of Syphilis: Elitza Theel, Ph.D.

109

A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.

110

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

111

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

112

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC

113

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

114

The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.

115

Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.

116

Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

117

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.

118

Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.

119

Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.

120

Congressional and Federal Updates: Bill Morice, M.D., Ph.D.

121

Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.

122

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.

123

Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.

124

A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

125

Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.

126

How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.

127

Transformative Technologies: Bill Morice, M.D., Ph.D.

128

Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.

129

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.

130

Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.

131

What to Know About Leprosy: Nancy Wengenack, Ph.D.

132

Flea-borne Typhus: Elitza Theel, Ph.D.

133

Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.

134

Summertime Pathogens: Bill Morice, M.D., Ph.D.

135

Modern-day Outbreaks: Bill Morice, M.D., Ph.D.

136

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.

137

Learning Through Teaching Global Health: Bill Morice, M.D., Ph.D.

138

Panel pinpoints causes of genetic hearing loss: Nicole Boczek, Ph.D., and Melanie Meyer, M.S, CGC

139

Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D.

140

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

141

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D.

142

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

143

Malaria in the United States: Bill Morice, M.D., Ph.D.

144

Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

145

The Latest on Measles: Matthew Binnicker, Ph.D.

146

Results report simplifies urine test interpretation: John Lieske, M.D.

147

FDA Oversight of Lab-Developed Tests: Bill Morice, M.D., Ph.D.

148

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC

149

Remote Diagnostics: Bill Morice, M.D., Ph.D.

150

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.

151

Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D.

152

BioPharma Diagnostics: Bill Morice, M.D., Ph.D.

153

The impact of AI: Bill Morice, M.D., Ph.D.

154

West Nile virus: Elitza Theel, Ph.D.

155

The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D.

156

Endemic fungal infections in North America: Elitza Theel, Ph.D.

157

A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter

158

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

159

Emerging fungal pathogens: Dr. Nancy Wengenack

160

Leading important industry conversations: Bill Morice, M.D., Ph.D.

161

IDH assay facilitates timelier leukemia treatment: Rong He, M.D.

162

Neurofilament light chain: Bjorn Oskarsson, M.D.

163

Approaching tick season: Bill Morice, M.D., Ph.D.

164

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.

165

Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D.

166

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D.

167

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D.

168

Amplifying the voice of the lab during policymaking: Dr. Bill Morice

169

Whole genome sequencing streamlines diagnosis: Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC

170

Rising rates of group A streptococcus and antibiotic resistant gonorrhea: Dr. Robin Patel

171

Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.

172

When to test for norovirus: Dr. Bill Morice

173

THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.

174

Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice

175

Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.

176

How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia

177

New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.

178

Triple-demic update and the future of at-home testing: Dr. Bill Morice

179

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

180

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

181

Legislative update and at-home testing: Dr. Bill Morice

182

Why cancer death rates are declining: Dr. Ansell

183

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

184

Predictions for 2023: Dr. Bill Morice

185

The laboratory’s role in spurring innovation: Dr. Bill Morice

186

Respiratory illness updates and health care economics: Dr. Bill Morice

187

Ensuring quality in the lab: Dr. Bill Morice

188

Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.

189

Staying safe during the holidays: Dr. Bill Morice

190

Carrier Screening: Linda Hasadsri, M.D., Ph.D.

191

The challenges facing most health care leaders: Dr. Bill Morice

192

Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.

193

Legislation, leadership, and MayoComplete: Dr. Bill Morice

194

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

195

Testing is essential in the months ahead: Dr. Bill Morice

196

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

197

Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.

198

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

199

Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.

200

Preparing for respiratory infection season: Dr. Matthew Binnicker

201

Chain of Custody Testing: Loralie Langman, Ph.D.

202

Shifting from pandemic to endemic: Dr. Bill Morice

203

Virus outlook heading into fall: Dr. Bill Morice

204

Advocating for lab legislation: Dr. Bill Morice

205

PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.

206

Leading diagnostics into the future: Dr. Bill Morice

207

PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.

208

PETH: Paul Jannetto, Ph.D.

209

Looking at the big picture: Dr. Bill Morice

210

Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.

211

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

212

Monkeypox and legislation updates: Dr. Bill Morice

213

CIDP: Divyanshu (Div) Dubey, M.B.B.S.

214

Ongoing evolution of monkeypox: Dr. Bill Morice

215

PMND1: John Lieske, M.D.

216

Monkeypox testing progress: Dr. Bill Morice

217

Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.

218

Operationalizing monkeypox testing: John Osborn

219

Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.

220

Monkeypox declared a global public health emergency: Dr. Bill Morice

221

FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.

222

Managing the current rise in COVID cases: Dr. Bill Morice

223

Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice

224

New SALSA bill and monkeypox testing at Mayo: Dr. Bill Morice

225

The Latest on Monkeypox and Lab Legislation: Dr. Bill Morice

226

The age of pandemics: Dr. Bill Morice

227

WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC

228

Monkeypox: Dr. Bill Morice

229

Being Mindful of Mental Health: John Black, M.D.

230

Viruses and variants: Dr. Bill Morice

231

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

232

VALID Act: Dr. Bill Morice

233

Tick-borne Disease Testing: Elitza Theel, Ph.D.

234

Lab Legislation Update: Dr. Bill Morice

235

NFLC: Alicia Algeciras, Ph.D.

236

Lab Medicine’s Role in the Clinical Practice: Dr. Bill Morice

237

ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.

238

Regulation of Lab Developed Tests: Dr. Bill Morice

239

Advancements in autoimmune neurology: Dr. Andrew McKeon

240

COVID-19 Update: Dr. Bill Morice

241

IBDP2: Melissa Snyder, Ph.D.

242

CLIA-Licensed Laboratories: Dr. Bill Morice

243

Chromium and Cobalt: Paul Jannetto, Ph.D.

244

Laboratory Innovation: Dr. Bill Morice

245

TPNUQ: Ann Moyer, M.D., Ph.D.

246

Lab developed tests: Dr. Bill Morice

247

MSP3: Maria Alice Willrich, Ph.D.

248

New COVID-19 variants: Dr. Bill Morice

249

Oversight of the laboratory industry: Dr. Bill Morice

250

Urinary ammonium testing: John Lieske, M.D.

251

New Strategies to Combat COVID-19: Dr. Bill Morice

252

New Masking Guidelines: Dr. Bill Morice

253

Extended spectrum beta lactamase testing: Audrey Schuetz, M.D.

254

Informatics and Laboratory Medicine: Dr. David McClintock

255

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

256

Adapting as COVID-19 Changes: Dr. Bill Morice

257

Interpreting Lab Test Results: Dr. Bill Morice

258

Tackling COVID-19 Misinformation: Dr. Bill Morice

259

A Global Perspective on COVID-19: Dr. Bill Morice

260

COVID-19 Antigen Tests: Dr. Bill Morice

261

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

262

Respiratory Virus Testing: Dr. Matthew Binnicker

263

Omicron Update: Dr. Bill Morice

264

Reflections on how far we’ve come: Dr. Bill Morice

265

Autoimmune Axonal Testing: Divyanshu (Div) Dubey, M.B.B.S.

266

At-Home COVID-19 Tests: Dr. Brad Karon

267

Holiday Safety and COVID-19: Dr. Bill Morice

268

The State of COVID-19 Now: Dr. Bill Morice

269

Omicron Variant: Dr. Bill Morice

270

CYPZ: Michelle Kluge, M.S., CGC

271

Lab-Developed Tests: Shannon Bennett

272

Hereditary Oncology Testing: Wei Shen, Ph.D.

273

COVID-19 Antibody Testing: Dr. Elitza Theel

274

IDENT: Audrey Schuetz, M.D.

275

COVID-19, Moving Forward: Dr. Bill Morice

276

The State of COVID-19 Today: Dr. Bill Morice

277

The Global Impact of COVID-19: Dr. Bill Morice

278

NF155: John Mills, Ph.D.

279

How AI is Shaping the Future of Laboratory Medicine: Dr. Bill Morice

280

Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

281

The Value of a Flu Vaccine Amid COVID-19: Dr. Bill Morice

282

T-cell Lymphoma Testing: Dr. Andrew Feldman

283

COVID-19 National Strategy: Dr. Bill Morice

284

PGXQP: Ann Moyer, M.D., Ph.D.

285

COVID-19 Vaccine Myths: Dr. Bill Morice & Dr. Matt Binnicker

286

COVID-19 Vaccine Boosters: Dr. Bill Morice

287

Candida Auris: Dr. Nancy Wengenack

288

COVID-19 Breakthrough Infections: Dr. Bill Morice

289

COVID-19 Update: Dr. Bill Morice

290

MAG Antibody Testing: John Mills, Ph.D.

291

COVID-19 Surge: Dr. Bill Morice

292

Coronavirus Delta Variant: Dr. Bill Morice

293

Vector-Borne Diseases: Dr. Bobbi Pritt & Dr. Bill Morice

294

Disaccharidase Activity Panel: Puanani (Pua) E. Hopson, D.O.

295

Lab fee reimbursement: Dr. Bill Morice

296

Kelch-11: Divyanshu (Div) Dubey, M.B.B.S.

297

The Current State of COVID-19: Dr. Bill Morice

298

NELL-1: Sanjeev Sethi, M.D., Ph.D.

299

Leading in Laboratory Medicine: Dr. Bill Morice

300

West Nile virus PCR testing: Bobbi Pritt, M.D.

301

MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

302

Mayo Clinic, Thermo Fisher Collaboration: Dr. Bill Morice

303

Laboratory Medicine After COVID-19: Dr. Bill Morice

304

TMA: Meera Sridharan, M.D., Ph.D.

305

Mayo Clinic Laboratories: Dr. Bill Morice

306

Lab Innovation During COVID-19: Dr. Bill Morice

307

Autoimmune Profile Updates: Andrew McKeon, M.B., B.Ch., M.D.

308

COVID-19 Vaccine Safety: Dr. Bill Morice

309

COVID-19 Testing Update: Joseph Yao, M.D.

310

Vaccine Passports: Dr. Bill Morice

311

Myasthenia Gravis: Christopher Klein, M.D.

312

COVID-19 Vaccine Update: Dr. Bill Morice

313

COVID-19 Vaccine Hesitancy: Dr. Bill Morice

314

The Path to Leadership: Dr. Bill Morice

315

Female Leadership at Mayo Clinic: Dr. Bill Morice

316

The Future of Lab Medicine Beyond COVID-19: Dr. Bill Morice

317

How COVID-19 Changed the Future of Lab Medicine: Dr. Bill Morice

318

Paraneoplastic Vision Loss Evaluation: Andrew McKeon, M,B., B.Ch., M.D.

319

The Impact of COVID-19 Variants: Dr. Matthew Binnicker

320

MASS-FIX: David Murray, M.D., Ph.D.

321

National COVID-19 Strategy: Dr. Bill Morice

322

Debunking COVID-19 Vaccine Myths: Dr. Bill Morice

323

Pancreatic Elastase Test: Puanani Hopson, D.O.

324

Laboratory Medicine in 2021 and Beyond: Dr. Bill Morice

325

COVID-19 Variants: Dr. Bill Morice

326

2020 COVID-19 Recap: Dr. Bill Morice

327

Dendritic Cell Enumeration Test: Amir Sadighi Akha, M.D., D.Phil.

328

Soaring Interest in Health Care Professions: Dr. Bill Morice

329

Updated Testing Algorithms for Plasma Cell Proliferative Disorders: Xinjie Xu, Ph.D.

330

Debunking Mask Myths: Dr. Bill Morice

331

Paraffin-Embedded Tissue Testing for COVID-19: Anja Roden, M.D.

332

Masks and COVID-19 Prevention: Dr. Bill Morice

333

Hereditary Hearing Loss: Nicole Boczek, Ph.D.

334

COVID-19 Vaccine Update: Dr. Bill Morice

335

COVID-19 Antibody Testing Update: Elitza Theel, Ph.D.

336

Treatment for COVID-19: Dr. Bill Morice

337

Alpha-Gal Testing: Joshua Bornhorst, Ph.D.

338

COVID-19 and Herd Immunity: Dr. Bill Morice

339

Distinguishing COVID-19 From Other Respiratory Illnesses: Aaron Tande, M.D.

340

COVID-19 Testing 101: Dr. Bill Morice

341

B-Cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease: Min Shi, M.D., Ph.D.

342

Enjoying Fall Activities Safely During COVID-19: Dr. Bill Morice

343

Coagulopathies and COVID-19: Nahla Heikal, M.D.

344

Staying Safe Amid a Surge in COVID-19: Dr. Bill Morice

345

MDM2 Gene Amplification: William Sukov, M.D.

346

Behind the Scenes in a Processing Lab During COVID-19: Jonathan Berry

347

COVID-19 – At-Home Sample Collection vs. At-Home Testing: Dr. Bill Morice

348

COVID Testing at Home: Dr. Bill Morice

349

Different Forms of Masking: Dr. Bill Morice

350

Quality Management during COVID-19: Jill Hill

351

Screening and Surveillance Testing: Dr. Bill Morice

352

Labor Day Weekend Precautions: Dr. Bill Morice

353

Laboratory Perspective of COVID-19: Aimee Boerger and Emily Fernholz

354

Leadership in a Time of Uncertainty: Dr. Bill Morice

355

Maximizing Testing Capacity: Dr. Bill Morice

356

Herd Immunity: Dr. Bill Morice

357

600th Case of the Week on Creepy Dreadful Wonderful Parasites: Dr. Bobbi Pritt

358

Pooling and Precautions: Dr. Bill Morice

359

Benefits of Wearing a Mask: Dr. Bill Morice

360

Supply Chain Management during COVID-19: Dr. Paul Jannetto

361

Delta Air Lines Partnership: Dr. Bill Morice

362

Neutralizing Antibody Assay, Explained: Dr. John Mills

363

Future of COVID-19 Laboratory Testing: Dr. Bill Morice

364

New COVID-19 Test Launch and Employee Testing: Dr. Bill Morice

365

Serology Testing for COVID-19: Dr. Elitza Theel

366

Innovation in COVID-19 Testing: Dr. Bill Morice

367

Using COVID-19 Testing to Help Restart the Economy: Dr. Bill Morice

368

Microbiology Leadership during the COVID-19 Pandemic: Dr. Robin Patel

369

Evolution of the COVID-19 Pandemic: Dr. Bill Morice

370

Podcasting Discussion with the Bow Tie Bandit of Blood: Dr. Justin Kreuter

371

State-Level Testing for COVID-19: Dr. Bill Morice

372

Increased PCR Testing Capacity for COVID-19: Dr. Joseph Yao

373

Leadership and Collaboration During COVID-19: Dr. Bill Morice

374

Drive-up Phlebotomy Services for Serology Testing: Nicole Kang

375

Minnesota Partnership for COVID-19 Pandemic: Dr. Bill Morice

376

Understanding COVID-19 Testing Options: Dr. Matt Binnicker

377

Leadership during the COVID-19 Pandemic: Dr. Bill Morice

378

Serology Testing for COVID-19: Dr. Elitza Theel

379

Coming Soon: Answers from the Lab Podcast